Investment Q&A

Q: Hello,

Any insight on this company? Management? I am wondering if you see any potential or if it’s too early? I am considering trimming Score and starting a position in Luck.

Thank you.

Q: What are your thoughts on the recent China deal? Any idea when funds will flow to the company from this deal?

Q: Please comment on the earnings released today. A turnaround situation. I like the proprietary part of their product and content demand is only growing. Good management.

Q: Good morning,
Thanks for your great service.
Today my question revolves around AU (gold) royalties and return of inflation - once the economy opens up & we start spending «en masse» our accumulated savings -.
I have read that royalties might be better than AU companies as they do not have the same cap ex as AU companies and they employ less human resources. I am assuming that they also have less debt on the balance sheet .
Questions:
Whether you prefer AU royalties vs AU etf or specific AU companies o even PHYS ?
Which royalty would you prefer ?
Would a precious metal royalty be a judicious addition to a portfolio ? Such as MMX, ALS, LIF ?
I am well diversified and have a substantial portfolio.
Deduct as many points as you see fit.
Best Regards,
Elaine

Q: Do we have an issue price for Topicus yet? My brokerage is showing a book cost of -$5.42. I don't see how one can have a negative book cost already.

Thanks!

Q: As a recovery play, and a 2 to 5 year horizon, specifically cruise lines, what is your opinion on CCL vs it's peers. If not CCL, what others would you recommend and why. CCL seems to be the biggest in terms of the number of sub groups under it. Is this size a negative though? Please provide some forward looking metrics to your recommended play

Q: This is a follow up question re buying Vestas wind OTC pink.
I have looked at the idea and tried to talk to my broker TD waterhouse but don't have the patience to wait for the phone to be answered.
I can't buy it from their website without calling.
Anyway I have given up on the idea of this company but would like a few suggestions for established wind turbine companies that operate internationally.
Many Thanks
Peter

Q: Hi group big loss today on HMMJ is the etf being effected by short trading how is this being done what is the chat rooms that i can log onto and watch what is going on thanks

Q: Thoughts on the quarter please?

Q: Could you please comment on Yeti as a potential investment and their most recent quarterly earnings?

Thanks very much

Kim

Q: KXS seems to be losing its momentum. It had been good for quite a while but now I am wondering if I should sell it and buy a more compelling company?

Thank you, Peter

Q: What is your opinion on AEM’s earn8 gs.
Would the 6% decline today make it a good entry point or would you wait?

Q: How were they're results? Guessing not so good basd on market reaction?

Q: Bombardier in the news today. The stock is up 10% since your last report. Any thoughts on recent events with respect to DOO?

Q: Hi gang,

I'm a little puzzled by the markets and analysts reaction to the CRH takeover. Is there something I'm missing?

Also if you can provide your quick analysis of how this impacts WELL going forward.

Thx

Q: In my earlier question about which stock to buy between PPL and KEY, you answered PPL. Can I have the reasons why?
Thanks, Martin

Q: Could you give a quick update on CRWD and reasons for the sharp increase in the last couple of days? Thank-you, your service is very much appreciated.

Q: What heck? (I am being kind) why would they do such as big reverse split when there shares were doing so well. They did Not need to do this much to satisfy a US listing. They just killed the momentum??? And leads to question about management competence.

Q: Mav has been showing good momentum lately but with very low volume, what can you tell me about them for an initial investment in regards to the management team, insider ownership and future prospects.
Thanx Gary

Q: Can you give an updated opinion of Novo, the balance sheet and earnings now that they've reported? With dominance in the diabetes space it would seem like a solid LT holding with a reasonable and growing dividend. Thanks!